PharmX and CH2 agree to expand partnership services

PharmX (ASX: PHX), Australia’s leading pharmacy ordering platform, and CH2, (part of Paragon Care Limited – ASX:PGC), one of the country’s prominent CSO wholesalers, are pleased to announce the expansion of their partnership. This enhanced collaboration focuses on elevating pharmacy engagement and leveraging market intelligence to drive dataled growth across Australia’s healthcare landscape.

Building upon their existing relationship, which has seen CH2 benefit from the PharmX Gateway—the leading EDI solution supporting orders for 99% of Australian pharmacies—the expanded alliance now includes the full suite of PharmX solutions. CH2 is broadening its product offering on PharmX’s Marketplace, adding over 10,000 products from
500 brands to meet pharmacies’ diverse and growing needs.

PharmX will also support CH2’s growth strategy through bespoke analytics services and predictive demand analytics. PharmX CEO, Tom Culver, said “We’re excited to strengthen our relationship with CH2 by offering our extended service portfolio that brings even greater value to our partners—not only for CH2 but also for our pharmacy customerExpanding CH2’s product range across our Marketplace strengthens our service offering and provides more accurate information on pricing and stock, which we know are highly valued by our pharmacy customers. We’re also seeing significant value in our data solutions. With our combined Gateway, Marketplace, and Analytics offerings, we are
thrilled to support CH2 in strengthening customer engagement while reinforcing our position as Australia’s largest pharmacy network provider.”

“Partnering with PharmX in this expanded capacity represents a significant milestone for CH2 as we continue to grow our reach amongst for Australian pharmacies,” said CH2 CEO, David Collins. “By leveraging PharmX’s full service offering, this partnership not only strengthens our engagement with existing customers but also allows us to connect
with new pharmacies across Australia, reinforcing CH2’s commitment to providing comprehensive, innovative solutions for the healthcare community.”
This strengthened relationship highlights PharmX and CH2’s shared vision for growth and innovation, aiming to enhance operations for pharmacies, ultimately driving long-term success across Australia’s healthcare landscape.

Must Read

PSA-credentialed pharmacists gain new official post-nominals

0
The Pharmaceutical Society of Australia (PSA) today announces new professional post-nominals for members who have achieved Medication Management Review (MMR) and Aged Care Onsite...